CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer

Together with its reported ability to modulate AKT phosphorylation (p-AKT) status in several tumor types, the oncoprotein CIP2A has been described to induce breast cancer progression and drug resistance. However, the clinical and therapeutic relevance of the CIP2A/AKT interplay in breast cancer rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Luque, Melani, Cristóbal, Ion, Sanz-Álvarez, Marta, Santos, Andrea, Zazo, Sandra, Eroles, Pilar, Arpí, Oriol, Rovira, Ana, Albanell, Joan, Madoz-Gúrpide, Juan, García-Foncillas, Jesús, Rojo, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955826/
https://www.ncbi.nlm.nih.gov/pubmed/35329936
http://dx.doi.org/10.3390/jcm11061610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955826/
https://www.ncbi.nlm.nih.gov/pubmed/35329936
http://dx.doi.org/10.3390/jcm11061610

Ejemplares similares